Kiyoto Kurima Phones & Addresses
-
9 Palmetto Ct, Germantown, MD 20874 (301) 515-9615
-
301 Side Dr, Gaithersburg, MD 20878 (240) 632-9263
-
Chicago, IL
-
Rockville, MD
-
Blacksburg, VA
-
Wooster, OH
Work
Position:
Professional/Technical
Education
Degree:
Associate degree or higher
Publications
Us Patents
Transductin-1 And Applications To Hereditary Deafness
View pageUS Patent:
7192705, Mar 20, 2007
Filed:
Sep 19, 2002
Appl. No.:
10/487887
Inventors:
Andrew J. Griffith - Montgomery Village MD, US
Kiyoto Kurima - Gaithersburg MD, US
Edward Wilcox - Gaithersburg MD, US
Thomas Friedman - Potomac MD, US
Kiyoto Kurima - Gaithersburg MD, US
Edward Wilcox - Gaithersburg MD, US
Thomas Friedman - Potomac MD, US
Assignee:
United States of America, represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
C12Q 1/68
G01N 33/53
G01N 33/53
US Classification:
435 6, 435 71
Abstract:
The invention provides methods of detecting hearing loss or a predisposition to hearing loss in an animal, which comprises detecting at least one mutation in a gene encoding transduction-1 (TDC1) in a test sample obtained from the animal. The invention also provides a method of determining the level of nucleic acid comprising a wild-type TDC1 gene and/or a mutant TDC1 gene in a test sample obtained from an animal.
Nucleic Acid Encoding Human Transductin-1 Polypeptide
View pageUS Patent:
7659115, Feb 9, 2010
Filed:
Dec 22, 2006
Appl. No.:
11/615250
Inventors:
Andrew Griffith - Rockville MD, US
Kiyoto Kurima - Gaithersburg MD, US
Edward Wilcox - Gaithersburg MD, US
Thomas Friedman - Potomac MD, US
Kiyoto Kurima - Gaithersburg MD, US
Edward Wilcox - Gaithersburg MD, US
Thomas Friedman - Potomac MD, US
Assignee:
The United States of America as represented by the Secretary of the Department of Health and Human Services - Washington DC
International Classification:
C07H 21/04
C12N 15/00
C12N 5/00
C12N 15/00
C12N 5/00
US Classification:
435325, 536 231, 536 235, 536 243, 4353201
Abstract:
The invention provides isolated or purified nucleic molecules consisting of a nucleotide sequence encoding human transductin-1 (TDC1), such as SEQ ID NO: 1. The invention also provides vectors comprising the isolated or purified nucleic acid sequences and cells comprising such vectors.
Transductin-1 And Transductin-2 And Applications To Hereditary Deafness
View pageUS Patent:
20050196759, Sep 8, 2005
Filed:
Mar 3, 2004
Appl. No.:
10/792307
Inventors:
Andrew Griffith - Rockville MD, US
Kiyoto Kurima - Gaithersburg MD, US
Edward Wilcox - Gaithersburg MD, US
Thomas Friedman - Potomac MD, US
Kiyoto Kurima - Gaithersburg MD, US
Edward Wilcox - Gaithersburg MD, US
Thomas Friedman - Potomac MD, US
Assignee:
The Govt. of the USA, as represented by the Secretary, Department of Health and Human Services - Rockville MD
International Classification:
C12Q001/68
C07H021/04
C12N015/09
C07K014/705
C07K016/28
C07H021/04
C12N015/09
C07K014/705
C07K016/28
US Classification:
435006000, 536023500, 435069100, 435320100, 435325000, 530350000, 530388220
Abstract:
The invention provides an isolated or purified nucleic acid molecule consisting essentially of the nucleotide sequence encoding transductin-2 (TDC2), related and derivative nucleic acid molecules, vectors comprising the isolated or purified nucleic acid sequences, cells comprising such vectors, polypeptides encoded by the nucleic acid molecules, monoclonal antibodies and cell lines producing the monoclonal antibodies. The invention also provides methods of treating, prognosticating and monitoring hearing loss.